SCHEMBL4151850

SCHEMBL4151850

CCc1nc(-c2ccc(Cl)cc2)nc(N2CCCCC2)c1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 4/20 0.48
FABP4 P15090 4/20 0.48
FABP5 Q01469 4/20 0.48
TP53 P04637 3/20 0.48
HPGD P15428 2/20 0.48
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
CYP2C9 P11712 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
LIPE Q05469 1/20 0.42
HSD17B10 Q99714 1/20 0.41
MAPT P10636 2/20 0.40
TSHR P16473 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8037289 0.87 GABRA2 (0.44) TP53HPGDADORA3ADORA2AADORA1
SCHEMBL4151852 0.83 ADORA3 (0.44) FABP3FABP4FABP5TP53HPGD
SCHEMBL5961069 0.79 FABP3 (0.49) FABP3FABP4FABP5TP53ADORA3
SCHEMBL4011568 0.75 FABP4 (0.42) FABP3FABP4FABP5TP53ADORA3
SCHEMBL4011470 0.74 FABP3 (0.45) FABP3FABP4FABP5HPGDADORA3
SCHEMBL4007857 0.74 FABP3 (0.45) FABP3FABP4FABP5TP53HPGD
SCHEMBL8043493 0.74 PLA2G1B (0.45) FABP3FABP4FABP5ADORA3ADORA2A
SCHEMBL8030010 0.74 RXRA (0.47) FABP3FABP4FABP5TP53HPGD
SCHEMBL4005140 0.73 FABP3 (0.44) FABP3FABP4FABP5TP53HPGD
SCHEMBL8025238 0.73 RXRA (0.48) FABP3FABP4FABP5TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed